Indication
Squamous-cell Non-Small-cell Lung Cancer
1 clinical trial
3 products
Clinical trial
A Multicenter Randomized Double-blinded Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of SCT-I10A or Placebo Plus Docetaxel in Treating Advanced Squamous Non-small Cell Lung CancerStatus: Terminated, Estimated PCD: 2023-02-23
Product
SCT-I10Product
PlaceboProduct
Docetaxel